Challenges in the Development of Novel Lipid Excipients for mRNA Lipid Nanoparticle Drug Products: A COVID-19 Vaccine Case Study
The presentation will focus on how the excipients in a topical semisolid product influence their physicochemical and structural (Q3) attributes, inviting the audience to consider how critical it is to control the Q3 attributes of the excipients, themselves, in order to control the quality and performance of semisolid drug products.
Track: Formulations
Presentation Level: Fundamental (requires little or no previous knowledge of the topic)
Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs
> Pharmaceutical - Originator Drugs
> Veterinary Medicine
> Consumer Goods (Medical Products)
Target Audience by Role:
> Formulations
> Commercial - Operations / Production
> Research & Development
> Quality
Note: Presentations are available for on-demand viewing for 21 days after purchase.
Track: Formulations
Presentation Level: Fundamental (requires little or no previous knowledge of the topic)
Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs
> Pharmaceutical - Originator Drugs
> Veterinary Medicine
> Consumer Goods (Medical Products)
Target Audience by Role:
> Formulations
> Commercial - Operations / Production
> Research & Development
> Quality
Note: Presentations are available for on-demand viewing for 21 days after purchase.